Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SSIC | US
0
0%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
13/09/2024
11.38
11.38
11.48
11.38
Silver Spike Investment Corp. is a a business development company. It is a specialty finance company focuses on investing across the cannabis ecosystem through investments in the form of direct loans to and equity ownership of privately held cannabis companies. It intends to partner with private equity firms entrepreneurs business owners and management teams to provide credit and equity financing alternatives to support buyouts recapitalizations growth initiatives refinancings and acquisitions across cannabis companies including cannabis-enabling technology companies cannabis-related health and wellness companies and hemp and CBD distribution companies. The company was founded in 2021 and is based in New York New York.
View LessLow 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
5.6%1 month
7.7%3 months
24.9%6 months
22.5%12.73
-
0.85
-
-
-
6.57
-
-
70.73M
70.73M
8.73
66.81
6.70
6.50
6.41
5.36
1.17
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.38
Range1M
0.59
Range3M
1.34
Rel. volume
0.53
Price X volume
12.62K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.51 | 49.72M | -1.95% | n/a | 318.92% |
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.097 | 48.88M | -7.97% | n/a | 0.00% |
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.46 | 48.08M | 8.96% | n/a | 25.73% |
Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 4.31 | 46.18M | 12.53% | 5.00 | 27.85% |
Qilian International Holding Group Limited | QLI | Drug Manufacturers-Specialty & Generic | 6.48 | 35.96M | 3.02% | n/a | 1.35% |
BGXX | BGXX | Drug Manufacturers-Specialty & Generic | 0.1986 | 31.30M | -2.65% | n/a | 5.20% |
India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3563 | 26.45M | 0.06% | n/a | 4.33% |
Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 4.61 | 25.12M | 12.99% | n/a | 0.00% |
MEI Pharma Inc | MEIP | Drug Manufacturers-Specialty & Generic | 3.03 | 20.19M | -0.98% | 0.79 | 22.86% |
Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 1.29 | 17.85M | -0.77% | n/a | 81.86% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Culp Inc | CULP | Textile Manufacturing | 5.72 | 75.14M | -2.56% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 2.965 | 26.61M | -13.30% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.1699 | 20.96M | -0.85% | n/a | 5.48% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.7456 | 10.41M | 7.76% | n/a | 422.08% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.07 | 10.31M | 35.44% | n/a | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.5337 | 4.94M | 18.60% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.31 | 3.62M | 1.55% | n/a | 9.62% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2475 | 3.40M | 15.12% | n/a | 0.97% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.7797 | 447.17K | -48.02% | n/a | 0.00% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.21 | 0 | -0.28% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | - | - |
Ent. to Revenue | 6.57 | - | Cheaper |
PE Ratio | 12.73 | 28.13 | Cheaper |
Price to Book | 0.85 | 11.07 | Cheaper |
Dividend Yield | 8.73 | - | Leader |
Std. Deviation (3M) | 24.94 | - | Lower Risk |
Debt to Equity | - | -0.91 | - |
Debt to Assets | - | 0.45 | - |
Market Cap | 70.73M | - | Emerging |